To CB2 or not CB2: Revisiting renoprotection in acute and chronic kidney injury
Fuente:
Wiley Open Access
Guardado en:
| Autores principales: | Jonathan M. de Jesus, Bob M. Moore, Frank Park |
|---|---|
| Formato: | Artículo Open Access |
| Publicado: |
Wiley
2025
|
| Materias: | |
| Acceso en línea: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
Activation of peripheral cannabinoid receptors by CB13 attenuates burn injury–induced chronic pain through TRP channel modulation
por: Obulapathi Ummadisetty, et al.
Publicado: (2026)
por: Obulapathi Ummadisetty, et al.
Publicado: (2026)
Allosterism in the adenosine A2A and cannabinoid CB2 heteromer
por: Claudia Llinas del Torrent, et al.
Publicado: (2024)
por: Claudia Llinas del Torrent, et al.
Publicado: (2024)
Cannabinoid CB2 receptor‐mediated analgesia: mechanism‐based insights and therapeutic potential
por: Kelsey G. Guenther, et al.
Publicado: (2025)
por: Kelsey G. Guenther, et al.
Publicado: (2025)
Single nucleotide polymorphisms in the cannabinoid CB2 receptor: Molecular pharmacology and disease associations
por: Tahira Foyzun, et al.
Publicado: (2024)
por: Tahira Foyzun, et al.
Publicado: (2024)
Multifactorial attribution for vancomycin‐associated acute kidney injury
por: Yu‐Ling Tseng, et al.
Publicado: (2026)
por: Yu‐Ling Tseng, et al.
Publicado: (2026)
Possible therapeutic repositioning of valproic acid: From epileptic seizures to acute kidney injury
por: Danilo Alves‐Bezerra, et al.
Publicado: (2026)
por: Danilo Alves‐Bezerra, et al.
Publicado: (2026)
Blockade of cannabinoid CB1 receptors potentiates the anti‐fibrotic effects mediated by SGLT2 inhibition in a mouse model of diabetic nephropathy
por: Océane Pointeau, et al.
Publicado: (2025)
por: Océane Pointeau, et al.
Publicado: (2025)
Metabolomic investigation of cisplatin‐induced acute kidney injury in paediatric cancer patients
por: Yong Jin Lim, et al.
Publicado: (2026)
por: Yong Jin Lim, et al.
Publicado: (2026)
Inhibition of peripheral CB 1 receptors modulates food intake and metabolic efficiency in obesity independently of the gut–brain vagal axis
por: Oriane Onimus, et al.
Publicado: (2026)
por: Oriane Onimus, et al.
Publicado: (2026)
The role of fluvoxamine in the treatment of endotoxin‐induced acute heart injury
por: Ilter Ilhan, et al.
Publicado: (2026)
por: Ilter Ilhan, et al.
Publicado: (2026)
Deacetylation of BAP31 by sirtuin 2 attenuates apoptosis of hepatocytes induced by endoplasmic reticulum stress, in chronic alcoholic liver injury
por: Sai Wang, et al.
Publicado: (2025)
por: Sai Wang, et al.
Publicado: (2025)
Inhibition of GRK2 mitigates cisplatin‐induced acute and chronic nephrotoxicity by targeting the NADPH oxidase 4/oxidative stress axis
por: Fei Duan, et al.
Publicado: (2026)
por: Fei Duan, et al.
Publicado: (2026)
Pharmacological inhibition of STING reduces neuroinflammation‐mediated damage post‐traumatic brain injury
por: Amelia L. Fryer, et al.
Publicado: (2024)
por: Amelia L. Fryer, et al.
Publicado: (2024)
Clinical outcomes associated with ACE inhibitors and ARBs use in adults older than 85 years who recovered from dialysis‐requiring acute kidney injury
por: Jui‐Yi Chen, et al.
Publicado: (2025)
por: Jui‐Yi Chen, et al.
Publicado: (2025)
Neurotoxicity from inordinate valacyclovir dosage in an elderly woman with stage 5 chronic kidney disease
por: Juan A. Vasquez Vasquez, et al.
Publicado: (2025)
por: Juan A. Vasquez Vasquez, et al.
Publicado: (2025)
Pharmacokinetic‐pharmacodynamic (PK/PD) modelling of cotadutide effect in patients with chronic kidney disease and type 2 diabetes mellitus
por: Hongtao Yu, et al.
Publicado: (2025)
por: Hongtao Yu, et al.
Publicado: (2025)
Predicting potassium trajectories for risk monitoring in outpatients with heart failure, diabetes mellitus or chronic kidney disease
por: Camilo Scherkl, et al.
Publicado: (2025)
por: Camilo Scherkl, et al.
Publicado: (2025)
Renoprotective effects of dapagliflozin in diabetic patients with chronic kidney disease: A retrospective observational study
por: Sara Al Lawati, et al.
Publicado: (2026)
por: Sara Al Lawati, et al.
Publicado: (2026)
Medication review interventions for adults living with advanced chronic kidney disease: A scoping review
por: Cathy Margaret Pogson, et al.
Publicado: (2024)
por: Cathy Margaret Pogson, et al.
Publicado: (2024)
Comment on ‘Renoprotective effects of dapagliflozin in diabetic patients with chronic kidney disease: A retrospective observational study’
por: Jia Chen, et al.
Publicado: (2026)
por: Jia Chen, et al.
Publicado: (2026)
Nanoliposomal Eucommia ulmoides extract limits PANoptosis in sepsis‐induced acute lung injury through a TGF‐β1–JNK pathway
por: Mingtao Deng, et al.
Publicado: (2026)
por: Mingtao Deng, et al.
Publicado: (2026)
Mechanism‐informed machine learning for individualized tacrolimus dose adjustment in the early post‐kidney transplant period
por: Hui Yu, et al.
Publicado: (2026)
por: Hui Yu, et al.
Publicado: (2026)
Revisiting the GRK2–NOX4 axis in cisplatin‐induced nephrotoxicity
por: Cheng Xue
Publicado: (2026)
por: Cheng Xue
Publicado: (2026)
FM‐dye inhibition of Piezo2 relieves mechanically evoked pain in mouse models of acute inflammatory and osteoarthritic knee pain
por: Natalie S. Adamczyk, et al.
Publicado: (2026)
por: Natalie S. Adamczyk, et al.
Publicado: (2026)
Pharmacological evaluation of non‐nucleotide purine derivatives as P2X7 antagonists for the treatment of neuroinflammation in traumatic brain injury
por: Inés Valencia, et al.
Publicado: (2025)
por: Inés Valencia, et al.
Publicado: (2025)
TNF‐ α partially modulates the endothelial dysfunction during the acute phase of Trypanosoma cruzi infection
por: Thales M. H. Dourado, et al.
Publicado: (2025)
por: Thales M. H. Dourado, et al.
Publicado: (2025)
IDH2‐NADPH pathway protects against acute pancreatitis via suppressing acinar cell ferroptosis
por: Qi Peng, et al.
Publicado: (2024)
por: Qi Peng, et al.
Publicado: (2024)
Commentary on: Activation of Nrf2 signalling pathway by tectoridin protects against ferroptosis in particulate matter‐induced lung injury
por: Wenfu Cao, et al.
Publicado: (2024)
por: Wenfu Cao, et al.
Publicado: (2024)
Identification of drug repurposing candidates for the treatment of polycystic kidney disease
por: Alina Meyer, et al.
Publicado: (2026)
por: Alina Meyer, et al.
Publicado: (2026)
Gut microbiota–derived trimethylamine‐N‐oxide protects pulmonary vascular barrier integrity via Vav guanine nucleotide exchange factor 3 (VAV3)‐mediated cytoskeletal remodelling in acute lung injury
por: Xilong Wang, et al.
Publicado: (2026)
por: Xilong Wang, et al.
Publicado: (2026)
Inhibition of sphingosine‐1‐phosphate receptor‐2 attenuates chronic gastritis via blocking nuclear translocation of S1P 2 receptors in epithelial cells
por: Ke‐Qin Li, et al.
Publicado: (2025)
por: Ke‐Qin Li, et al.
Publicado: (2025)
Ginsenoside Rf protects against acetaminophen‐induced liver injury by targeting CCAR2 to activate the SIRT1‐FXR signalling pathway
por: Jingjing Fan, et al.
Publicado: (2026)
por: Jingjing Fan, et al.
Publicado: (2026)
Exploring effects of chronic d ‐cycloserine administration on expression of GluN2 subunits and tripartite synaptic transmission in thalamocortical pathway
por: Motohiro Okada, et al.
Publicado: (2025)
por: Motohiro Okada, et al.
Publicado: (2025)
TREM2 activation suppresses central sensitisation by promoting autophagy in a chronic migraine model with recurrent nitroglycerin stimulation in mice
por: Suifa Hu, et al.
Publicado: (2026)
por: Suifa Hu, et al.
Publicado: (2026)
Psilocybin as a novel treatment for chronic pain
por: Tate Askey, et al.
Publicado: (2024)
por: Tate Askey, et al.
Publicado: (2024)
TREM2 activation reduces white matter injury via PI3K/Akt/GSK‐3β signalling after intracerebral haemorrhage
por: Yuan Zhang, et al.
Publicado: (2025)
por: Yuan Zhang, et al.
Publicado: (2025)
Plumbagin, a novel TRPV2 inhibitor, ameliorates microglia activation and brain injury in a middle cerebral artery occlusion/reperfusion mouse model
por: Meihuizi Ding, et al.
Publicado: (2024)
por: Meihuizi Ding, et al.
Publicado: (2024)
Sevoflurane protects against testicular ischaemia–reperfusion injury in rats
por: Jiaxue Li, et al.
Publicado: (2026)
por: Jiaxue Li, et al.
Publicado: (2026)
Reply to the Letter to the Editor from Chen Xue entitled “Revisiting the GRK2–NOX4 axis in cisplatin‐induced nephrotoxicity.”
por: Fei Duan, et al.
Publicado: (2026)
por: Fei Duan, et al.
Publicado: (2026)
Impact of CYP2D6*2A, CYP2D6*4 and CYP3A5*3 genetic polymorphisms on Bisoprolol peak concentration and clinical response in acute coronary syndrome patients
por: Sherouk M. Okda, et al.
Publicado: (2024)
por: Sherouk M. Okda, et al.
Publicado: (2024)
Ejemplares similares
-
Activation of peripheral cannabinoid receptors by CB13 attenuates burn injury–induced chronic pain through TRP channel modulation
por: Obulapathi Ummadisetty, et al.
Publicado: (2026) -
Allosterism in the adenosine A2A and cannabinoid CB2 heteromer
por: Claudia Llinas del Torrent, et al.
Publicado: (2024) -
Cannabinoid CB2 receptor‐mediated analgesia: mechanism‐based insights and therapeutic potential
por: Kelsey G. Guenther, et al.
Publicado: (2025) -
Single nucleotide polymorphisms in the cannabinoid CB2 receptor: Molecular pharmacology and disease associations
por: Tahira Foyzun, et al.
Publicado: (2024) -
Multifactorial attribution for vancomycin‐associated acute kidney injury
por: Yu‐Ling Tseng, et al.
Publicado: (2026)